Loading chat...
CT SB00694
Bill
Status
Passed
7/12/2021
Primary Sponsor
General Law Committee
Click for details
AI Summary
- Exempts veterinarians licensed under chapter 384 from reporting insulin drugs, glucagon drugs, diabetes devices, and diabetic ketoacidosis devices to the Prescription Drug Monitoring Program when dispensed for animal patients
- Requires pharmacies, nonresident pharmacies, outpatient hospital/institutional pharmacies, and other dispensers to report all insulin and glucagon drugs and diabetes devices to the commissioner at least daily by electronic means or commissioner-approved format
- Maintains reporting requirement for human patients dispensed insulin drugs, glucagon drugs, diabetes devices, and diabetic ketoacidosis devices through pharmacies and outpatient pharmacies
- Requires reporting to follow the same manner and procedures used for controlled substance prescription reporting under subdivision (4) of subsection (j) of section 21a-254
- Effective from passage
Legislative Description
An Act Exempting Veterinarians From The Requirement To Report Certain Dispensed Diabetes Drugs And Devices To The Prescription Drug Monitoring Program.
Last Action
Signed by the Governor
7/12/2021
Committee Referrals
General Law1/28/2021
Full Bill Text
No bill text available